Cardiac computed tomography‐derived myocardial tissue characterization after anthracycline treatment
Abstract Aims Understanding cardiac function after anthracycline administration is very important from the perspective of preventing the onset of heart failure. Although cardiac magnetic resonance and echocardiography are recognized as the ‘gold standard’ for detecting cardiotoxicity, they have many...
Saved in:
Main Authors: | Koichi Egashira, Daisuke Sueta, Masafumi Kidoh, Mai Tomiguchi, Seitaro Oda, Hiroki Usuku, Kaori Hidaka, Lisa Goto‐Yamaguchi, Aiko Sueta, Takashi Komorita, Fumi Oike, Koichiro Fujisue, Eiichiro Yamamoto, Shinsuke Hanatani, Seiji Takashio, Satoshi Araki, Kenichi Matsushita, Yutaka Yamamoto, Toshinori Hirai, Kenichi Tsujita |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13867 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of left atrial and ventricular strain for diagnosis of transthyretin amyloid cardiomyopathy in aortic stenosis
by: Fumi Oike, et al.
Published: (2022-06-01) -
A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients
by: Bo Dai, et al.
Published: (2025-01-01) -
Advancements in Managing Anthracycline-Induced Cardiotoxicity: Insights from Interventional Clinical Trials
by: Zhao M, et al.
Published: (2025-01-01) -
A simple staging system using biomarkers for wild‐type transthyretin amyloid cardiomyopathy in Japan
by: Naoya Nakashima, et al.
Published: (2022-06-01) -
Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study
by: Xinye Li, et al.
Published: (2025-03-01)